1-201043356-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000362061.4(CACNA1S):​c.4973G>A​(p.Arg1658His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.058 in 1,613,994 control chromosomes in the GnomAD database, including 4,663 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1658C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.11 ( 1603 hom., cov: 32)
Exomes 𝑓: 0.053 ( 3060 hom. )

Consequence

CACNA1S
ENST00000362061.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.253

Publications

20 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • congenital myopathy 18
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital myopathy
    Inheritance: SD, AR, AD Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019210279).
BP6
Variant 1-201043356-C-T is Benign according to our data. Variant chr1-201043356-C-T is described in ClinVar as Benign. ClinVar VariationId is 254842.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.257 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000362061.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.4973G>Ap.Arg1658His
missense
Exon 40 of 44NP_000060.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.4973G>Ap.Arg1658His
missense
Exon 40 of 44ENSP00000355192.3
CACNA1S
ENST00000367338.7
TSL:5
c.4916G>Ap.Arg1639His
missense
Exon 39 of 43ENSP00000356307.3
CACNA1S
ENST00000681874.1
c.4913G>Ap.Arg1638His
missense
Exon 39 of 43ENSP00000505162.1

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16326
AN:
152024
Hom.:
1596
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.261
Gnomad AMI
AF:
0.0471
Gnomad AMR
AF:
0.0485
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0321
Gnomad FIN
AF:
0.0577
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.0502
Gnomad OTH
AF:
0.0814
GnomAD2 exomes
AF:
0.0613
AC:
15403
AN:
251446
AF XY:
0.0577
show subpopulations
Gnomad AFR exome
AF:
0.271
Gnomad AMR exome
AF:
0.0342
Gnomad ASJ exome
AF:
0.103
Gnomad EAS exome
AF:
0.000762
Gnomad FIN exome
AF:
0.0574
Gnomad NFE exome
AF:
0.0525
Gnomad OTH exome
AF:
0.0637
GnomAD4 exome
AF:
0.0528
AC:
77180
AN:
1461852
Hom.:
3060
Cov.:
31
AF XY:
0.0516
AC XY:
37498
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.268
AC:
8984
AN:
33476
American (AMR)
AF:
0.0375
AC:
1675
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.100
AC:
2625
AN:
26136
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39686
South Asian (SAS)
AF:
0.0371
AC:
3204
AN:
86258
European-Finnish (FIN)
AF:
0.0563
AC:
3006
AN:
53420
Middle Eastern (MID)
AF:
0.0928
AC:
535
AN:
5768
European-Non Finnish (NFE)
AF:
0.0478
AC:
53182
AN:
1111988
Other (OTH)
AF:
0.0656
AC:
3960
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4225
8450
12676
16901
21126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2088
4176
6264
8352
10440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16351
AN:
152142
Hom.:
1603
Cov.:
32
AF XY:
0.106
AC XY:
7861
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.261
AC:
10833
AN:
41468
American (AMR)
AF:
0.0485
AC:
741
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
350
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.0323
AC:
156
AN:
4828
European-Finnish (FIN)
AF:
0.0577
AC:
611
AN:
10590
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0502
AC:
3413
AN:
68004
Other (OTH)
AF:
0.0806
AC:
170
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
686
1372
2058
2744
3430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0711
Hom.:
1688
Bravo
AF:
0.114
TwinsUK
AF:
0.0464
AC:
172
ALSPAC
AF:
0.0532
AC:
205
ESP6500AA
AF:
0.253
AC:
1116
ESP6500EA
AF:
0.0530
AC:
456
ExAC
AF:
0.0656
AC:
7965
Asia WGS
AF:
0.0270
AC:
94
AN:
3478
EpiCase
AF:
0.0517
EpiControl
AF:
0.0508

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Malignant hyperthermia, susceptibility to, 5 (3)
-
-
3
not specified (3)
-
-
2
Hypokalemic periodic paralysis, type 1 (2)
-
-
1
Congenital myopathy 18 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)
-
-
1
not provided (1)
-
-
1
Thyrotoxic periodic paralysis, susceptibility to, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.0073
T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
2.0
M
PhyloP100
-0.25
PrimateAI
Benign
0.33
T
PROVEAN
Benign
1.3
N
REVEL
Benign
0.24
Sift
Benign
0.31
T
Sift4G
Benign
0.20
T
Polyphen
0.0
B
Vest4
0.043
MPC
0.13
ClinPred
0.031
T
GERP RS
1.6
Varity_R
0.090
gMVP
0.50
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13374149; hg19: chr1-201012484; COSMIC: COSV62942163; COSMIC: COSV62942163; API